Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Jul;95(7):1226-7.
doi: 10.3324/haematol.2010.023390.

No association between myeloproliferative neoplasms and the Crohn's disease-associated STAT3 predisposition SNP rs744166

Comment

No association between myeloproliferative neoplasms and the Crohn's disease-associated STAT3 predisposition SNP rs744166

Amy V Jones et al. Haematologica. 2010 Jul.

Erratum in

  • Haematologica. 2010 Dec;95(12):2166
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica. 2010;95(7):1216–20. - PMC - PubMed
    1. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40(8):955–62. - PMC - PubMed
    1. Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, Russell RK, et al. Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease. Am J Hum Genet. 2009;84(3):399–405. - PMC - PubMed
    1. Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut. 2009;58(8):1152–67. - PubMed
    1. Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet. 2009;41(4):446–9. - PMC - PubMed

MeSH terms

Substances